Huinan Changlong Says Planned Allocations Cover About 90% of Cash and Short-Term InvestmentsPUBT·Nov 10, 2026 at 10:09 AM08049-2.06%
Cement and Energy Stocks Drive Hong Kong Small-Cap Divergence Through Overseas ExpansionGlobal Report·Oct 28, 2026 at 09:20 AM08268+7.69%002370.00%
Cardiovascular Innovators Outpace Traditional Drugmakers in Hong Kong Healthcare ShiftGlobal Report·Oct 22, 2026 at 09:14 AM09996+1.23%08049-2.06%
Jilin Province Huinan Changlong Bio-Pharmacy FY26 H1 profit attributable to shareholders rises 19.25% to RMB 122.84 million; revenue slips 0.87% to RMB 435.05 millionPUBT·Aug 14, 2026 at 02:23 PM08049-2.06%
Offshore Capital Reassesses Hong Kong Periphery as Property Liquidations Contrast with Green ResilienceGlobal Report·Aug 11, 2026 at 09:42 AM03613-0.09%08049-2.06%
Huinan Changlong Bio-Pharmacy schedules board meeting to review interim resultsPUBT·Aug 4, 2026 at 11:13 AM08049-2.06%
Morning Trend | JILIN CHANGLONG's main force tests again, is a medium-term swing opportunity emerging?Technical Forecast·Nov 21, 2025 at 01:00 AM08049-2.06%
JILIN CHANGLONG subscribed to RMB 50 million of China Industrial and Commercial Bank wealth management productsZhitong·Aug 25, 2025 at 11:05 AM601398+0.11%01398-1.05%
JILIN CHANGLONG subscribed to ICBC wealth management products worth 50 million yuanZhitong·Aug 21, 2025 at 10:45 AM601398+0.11%01398-1.05%
JILIN CHANGLONG released its interim results, with a profit attributable to shareholders of 103 million yuan, a year-on-year decrease of 1.2%Zhitong·Aug 14, 2025 at 01:25 PM08049-2.06%
Zhitong Hong Kong Stock Investment Journal | July 18Zhitong·Jul 17, 2025 at 04:02 PM03616-10.43%08049-2.06%